Tenax shares rise as company finds new path for levo June 2, 2020 By Michael Fitzhugh No Comments Levosimendan's long story took a new turn with results from a phase II trial testing chronic administration of the calcium sensitizer in patients with pulmonary hypertension associated with heart failure and preserved ejection fraction (PH-HFpEF).Read More